Finance

Lists
BIOA:NASDAQ
BIOAGE Labs Inc
$10.40
-1.89%
(-0.20) 1D
$10.42
+0.22% (+0.023)
After hours
Closed: Aug 17, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOA...
Open
$10.60
High
$10.71
Low
$10.14
Mkt. cap
477.33M
Avg. vol.
1.10M
Volume
0.00
52-wk high
$25.96
52-wk low
$4.38
EPS
-$2.39
Shares outstanding
45.90M
No. of employees
61
Open
$10.60
High
$10.71
Low
$10.14
Mkt. cap
477.33M
Avg. vol.
1.10M
Volume
0.00
52-wk high
$25.96
52-wk low
$4.38
EPS
-$2.39
Shares outstanding
45.90M
No. of employees
61
News stories
From web sources and news partners
About BIOAGE Labs Inc
CEO-
Employees61
Founded2015
HeadquartersEmeryville, California, United States
SectorPharmaceutical industry
Websitebioagelabs.com
Analyst ratings
Based on 9 analysts giving stock ratings to BIOA in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for BIOA in the last 3 months.
Highest
Current $10.40
$73.00 (+601.92%)
Average
$35.63 (+242.60%)
Lowest
$20.00 (+92.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ulz
Morgan Stanley
Hold
Maintained
$20.00
+92.3%
08/07/2026
Adam Walsh
Roth MKM
Buy
Maintained
$25.00
+140.4%
08/07/2026
Jay Olson
Oppenheimer
Buy
Maintained
$50.00
+380.8%
08/06/2026
Joseph Stringer
Needham
Buy
Maintained
$35.00
+236.5%
08/06/2026
Samantha Semenkow
Citi
Buy
Maintained
$21.00
+101.9%
08/06/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Reiterated
$73.00
+601.9%
08/06/2026
Thomas Shrader
BTIG
Buy
Maintained
$40.00
+284.6%
08/05/2026
Roger Song
Jefferies
Buy
Maintained
$21.00
+101.9%
07/31/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.58 / -$0.62
+7.09%beat
Revenue / Est. (USD)
2.45M / 1.50M
+63.65%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.05M
3.08M
2.77M
2.45M
Cost of goods sold
18.51M
24.50M
20.41M
24.36M
Cost of revenue
18.51M
24.50M
20.41M
24.36M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.68M
7.00M
7.74M
7.42M
Operating expense
6.68M
7.00M
7.74M
7.42M
Total operating expenses
25.19M
31.50M
28.15M
31.78M
Operating income
-23.14M
-28.42M
-25.38M
-29.33M
Other non operating income
-42.00K
-220.00K
-107.00K
-201.00K
EBT including unusual items
-20.17M
-25.94M
-22.25M
-26.10M
EBT excluding unusual items
-20.17M
-25.94M
-22.25M
-26.10M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.17M
-25.94M
-22.25M
-26.10M
Net profit margin
-982.03%
-842.85%
-802.78%
-1,064.75%
Earnings per share
-0.56
-0.72
-0.52
-0.58
Interest and investment income
3.16M
2.79M
3.27M
3.44M
Interest expense
-149.00K
-92.00K
-39.00K
-1.00K
Net interest expenses
3.01M
2.70M
3.23M
3.44M
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.09M
-28.35M
-25.31M
-29.26M
Gain or loss from assets sale
-
23.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps